Cargando…
Targeting mTOR and eIF4E: a feasible scenario in ovarian cancer therapy
Ovarian carcinoma is one of the most common causes for cancer death in women; lack of early diagnosis and acquired resistance to platinum-based chemotherapy account for its poor prognosis and high mortality rate. As with other cancer types, ovarian cancer is characterized by dysregulated signaling p...
Autores principales: | Romagnoli, Alice, Maracci, Cristina, D’Agostino, Mattia, Teana, Anna La, Marino, Daniele Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094073/ https://www.ncbi.nlm.nih.gov/pubmed/35582305 http://dx.doi.org/10.20517/cdr.2021.20 |
Ejemplares similares
-
Control of the eIF4E activity: structural insights and pharmacological implications
por: Romagnoli, Alice, et al.
Publicado: (2021) -
The Role of mTOR and eIF Signaling in Benign Endometrial Diseases
por: Driva, Tatiana S., et al.
Publicado: (2022) -
mTOR inhibitor efficacy is determined by the eIF4E/4E-BP ratio
por: Alain, Tommy, et al.
Publicado: (2012) -
Insights Into the Binding Mechanism of GC7 to Deoxyhypusine Synthase in Sulfolobus solfataricus: A Thermophilic Model for the Design of New Hypusination Inhibitors
por: D'Agostino, Mattia, et al.
Publicado: (2020) -
eIF4E3 forms an active eIF4F complex during stresses (eIF4F(S)) targeting mTOR and re-programs the translatome
por: Weiss, Benjamin, et al.
Publicado: (2021)